In the BioHarmony Drug Report Database

"Preview" Icon

Nevirapine

Viramune (nevirapine) is a small molecule pharmaceutical. Nevirapine was first approved as Viramune on 1996-06-21. It is used to treat acquired immunodeficiency syndrome and HIV infections in the USA. It has been approved in Europe to treat HIV infections. Viramune’s patent is valid until 2029-03-12 (FDA).

 

Trade Name

 

Viramune
 

Common Name

 

nevirapine
 

ChEMBL ID

 

CHEMBL57
 

Indication

 

acquired immunodeficiency syndrome, hiv infections
 

Drug Class

 

Tricyclic compounds; antivirals

Image (chem structure or protein)

Nevirapine structure rendering